Welcome to the working week
. We hope you had an enjoyable, or at least interesting, weekend. The ASCO meeting, which will wind down tomorrow, generated some notable headlines and a few more developments can be found below.
Call this an ASCO round-up
. So as you prepare for meetings and deadlines, dig in...
New Hope For Astra-Zeneca's Iressa? (BusinessWeek)
Celebrex May Hold Promise In Preventing Lung Cancer (Yahoo/Reuters)
ImClone's Erbitux Seen As Limited Threat To Avastin (Bloomberg News)
Test May Predict Cancer Response To Anemia Meds (Yahoo/Reuters)